Company / Debt per Share
Emergent BioSolutions Inc. Debt per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$11.32
FY2025
5-year range
$11.32 / $27.56
FY2021-FY2025
Trend
-12.2%
vs FY2024
Sector context
#25 of 82
Health Care
What the data says
At $11.32, Emergent BioSolutions Inc.'s debt per share ranks #58 of 82 in the Health Care sector. Debt per Share has declined for 3 consecutive years, from $27.56 in FY2022 to $11.32 in FY2025.
Based on SEC 10-K filings.
11.32 in FY2025 with a 5-year CAGR of -8.0%.
Improved from $16.64 to $11.32 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -25.7%
- 5-Year CAGR
- -8.0%
- 10-Year CAGR
- -
Sector benchmark
#58 of 82 in Health CareTop 70% of 82This company $11.32 Sector average $151.59
▼
-92.5% below sector average
Key checks
Key Insights
- Emergent BioSolutions Inc.'s debt per share has declined for 3 consecutive years.
- In FY2025, debt per share decreased 12.2% year-over-year.
- Ranks #25 out of 82 companies in the Health Care sector.
- Peak debt per share was recorded in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.32 | -12.2% |
| FY2024 | $12.89 | -22.5% |
| FY2023 | $16.64 | -39.6% |
| FY2022 | $27.56 | +66.4% |
| FY2021 | $16.56 | -3.3% |
| FY2020 | $17.13 | +7.7% |
| FY2019 | $15.91 | -2.8% |
| FY2018 | $16.37 | +4784.5% |
| FY2017 | $0.34 | -94.7% |
| FY2016 | $6.30 | -3.8% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026